SetPoint Medical Presents 24-Month Data Demonstrating Sustained Clinical Benefit and Favorable Long-Term Safety of the SetPoint® System for Rheumatoid Arthritis

Markets PR Newswire By PR Newswire 09 Nov 2026 15:30 1 min read
SetPoint Medical Presents 24-Month Data Demonstrating Sustained Clinical Benefit and Favorable Long-Term Safety of the SetPoint® System for Rheumatoid Arthritis

Findings presented at ACR Convergence 2026 reinforce the long-term potential of neuroimmune modulation as a durable treatment approach for people living with rheumatoid arthritis SANTA CLARITA, Calif., Nov. 9, 2026 /PRNewswire/ -- SetPoint Medical, a company dedicated to developing...

Covered in this story

Call it yourself

No calls on $ACR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Acres Commercial Realty Corp →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.